Neurocrine Biosciences Inc NBIX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
136.15UNCH (UNCH)
Volume
62,471
Close
136.15quote price arrow down-0.55 (-0.40%)
Volume
648,710
52 week range
89.04 - 148.37
Loading...
  • Open138.00
  • Day High138.68
  • Day Low135.23
  • Prev Close136.70
  • 52 Week High148.37
  • 52 Week High Date03/21/24
  • 52 Week Low89.04
  • 52 Week Low Date05/30/23

Key Stats

  • Market Cap13.702B
  • Shares Out100.64M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change3.33

KEY STATS

  • Open138.00
  • Day High138.68
  • Day Low135.23
  • Prev Close136.70
  • 52 Week High148.37
  • 52 Week High Date03/21/24
  • 52 Week Low89.04
  • 52 Week Low Date05/30/23
  • Market Cap13.702B
  • Shares Out100.64M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change3.33

RATIOS/PROFITABILITY

  • EPS (TTM)3.64
  • P/E (TTM)37.41
  • Fwd P/E (NTM)29.20
  • EBITDA (TTM)492.90M
  • ROE (TTM)18.16%
  • Revenue (TTM)1.982B
  • Gross Margin (TTM)98.05%
  • Net Margin (TTM)18.65%
  • Debt To Equity (MRQ)5.15%

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neurocrine Biosciences Inc

Profile

MORE
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering and developing pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive...
William Rastetter Ph.D.
Non-Executive Independent Chairman of the Board
Kevin Gorman Ph.D.
Chief Executive Officer, Director
Matthew Abernethy CPA
Chief Financial Officer
Address
6027 EDGEWOOD BEND COURT
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
MEDP
Medpace Holdings Inc
389.27-0.92-0.24%
SRPT
Sarepta Therapeutics Inc
131.70-0.12-0.09%
ALNY
Alnylam Pharmaceuticals Inc
149.89-0.58-0.39%
EXAS
Exact Sciences Corp
55.59+2.08+3.89%
NTRA
Natera Inc
103.33-1.96-1.86%